Global (United States, European Union and China) Neuroendoscopy

Neuroendoscopy Comprehensive Study by Type (Rigid Neuroendoscopes, Flexible Neuroendoscopes), Application (Transnasal, Intraventricular, Transcranial), Usability (Reusable, Disposable), End User (Hospitals, Surgical Centers), Tumor Type (Pituitary tumours, Tumors in the pineal region, Rathke’s cleft cysts, Tumors in the base of the skull, Ventricular tumours) Players and Region - Global Market Outlook to 2026

Neuroendoscopy Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Neuroendoscopy Market Scope?
The neuro endoscope can be used to implement the complete minimally invasive operation, normally through a small hole smaller than the size of a dime, or in combination with the surgical microscope. Neroendoscopy refers to a minimally invasive technique used to remove brain tumours during brain surgery is called neroendoscopy. The neurosurgeon accesses the brain and removes the tumour through small holes in the skull. Neuroendoscopy is done by using an endoscope on the end to help the neurosurgeon to navigate and access the tumour. In order to exclude a tumour or take a sample of it, neurosurgeons attach special instruments to the endoscope, often an added endoscope with and scissors on the end, as opposed to conventional open brain surgery, which needs more time for healing post-surgery and induces less pain. These advantages are being examined widely in the medical community and therefore, these methods are growing more common worldwide. The advantages of neuroendoscopic surgery over traditional brain surgery are expected to drive the growth of the market.

The Neuroendoscopy market study is being classified by Type (Rigid Neuroendoscopes and Flexible Neuroendoscopes), by Application (Transnasal, Intraventricular and Transcranial) and major geographies with country level break-up.

The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that Players from Germany will contribute to the maximum growth of Global Neuroendoscopy market throughout the predicted period.

KARL STORZ (Germany), B. Braun (Germany), Ackermann Instrumente (Germany), Adeor Medical (Germany), Hangzhou Hawk Optical Electronic Instruments (China), Machida Endoscope (Japan), Tonglu Wanhe Medical Instrument (China), Schindler Endoskopie (Germany), Clarus Medical (United States) and LocaMed (United Kingdom) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Visionsense Corporation (United States).

Segmentation Analysis
Analyst at AMA have segmented the market study of Global Neuroendoscopy market by Type, Application and Region.

On the basis of geography, the market of Neuroendoscopy has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).




Influencing Market Trend
  • Government Initiatives for improving the health care sector

Market Drivers
  • Rising Prevalence of Neurological Disorders
  • Benefits of Neuroendoscopic Surgery Over Conventional Brain Surgery

Opportunities
  • Growing prevalence of neurological disorders and favourable government initiatives.

Restraints
  • High Cost of Neuroendoscopy Procedures & Equipment

Challenges
  • Shortage of Trained Neurologists and Endoscopists


Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Neuroendoscopy Manufacturer, Government Regulatory and Research Organizations and End-Use Industry

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research & Media features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.

Report Objectives / Segmentation Covered

By Type
  • Rigid Neuroendoscopes
  • Flexible Neuroendoscopes
By Application
  • Transnasal
  • Intraventricular
  • Transcranial
By Usability
  • Reusable
  • Disposable

By End User
  • Hospitals
  • Surgical Centers

By Tumor Type
  • Pituitary tumours
  • Tumors in the pineal region
  • Rathke’s cleft cysts
  • Tumors in the base of the skull
  • Ventricular tumours

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Prevalence of Neurological Disorders
      • 3.2.2. Benefits of Neuroendoscopic Surgery Over Conventional Brain Surgery
    • 3.3. Market Challenges
      • 3.3.1. Shortage of Trained Neurologists and Endoscopists
    • 3.4. Market Trends
      • 3.4.1. Government Initiatives for improving the health care sector
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Neuroendoscopy, by Type, Application, Usability, End User, Tumor Type and Region (value, volume and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Neuroendoscopy (Value)
      • 5.2.1. Global Neuroendoscopy by: Type (Value)
        • 5.2.1.1. Rigid Neuroendoscopes
        • 5.2.1.2. Flexible Neuroendoscopes
      • 5.2.2. Global Neuroendoscopy by: Application (Value)
        • 5.2.2.1. Transnasal
        • 5.2.2.2. Intraventricular
        • 5.2.2.3. Transcranial
      • 5.2.3. Global Neuroendoscopy by: Usability (Value)
        • 5.2.3.1. Reusable
        • 5.2.3.2. Disposable
      • 5.2.4. Global Neuroendoscopy by: End User (Value)
        • 5.2.4.1. Hospitals
        • 5.2.4.2. Surgical Centers
      • 5.2.5. Global Neuroendoscopy Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Neuroendoscopy (Volume)
      • 5.3.1. Global Neuroendoscopy by: Type (Volume)
        • 5.3.1.1. Rigid Neuroendoscopes
        • 5.3.1.2. Flexible Neuroendoscopes
      • 5.3.2. Global Neuroendoscopy by: Application (Volume)
        • 5.3.2.1. Transnasal
        • 5.3.2.2. Intraventricular
        • 5.3.2.3. Transcranial
      • 5.3.3. Global Neuroendoscopy by: Usability (Volume)
        • 5.3.3.1. Reusable
        • 5.3.3.2. Disposable
      • 5.3.4. Global Neuroendoscopy by: End User (Volume)
        • 5.3.4.1. Hospitals
        • 5.3.4.2. Surgical Centers
      • 5.3.5. Global Neuroendoscopy Region
        • 5.3.5.1. South America
          • 5.3.5.1.1. Brazil
          • 5.3.5.1.2. Argentina
          • 5.3.5.1.3. Rest of South America
        • 5.3.5.2. Asia Pacific
          • 5.3.5.2.1. China
          • 5.3.5.2.2. Japan
          • 5.3.5.2.3. India
          • 5.3.5.2.4. South Korea
          • 5.3.5.2.5. Taiwan
          • 5.3.5.2.6. Australia
          • 5.3.5.2.7. Rest of Asia-Pacific
        • 5.3.5.3. Europe
          • 5.3.5.3.1. Germany
          • 5.3.5.3.2. France
          • 5.3.5.3.3. Italy
          • 5.3.5.3.4. United Kingdom
          • 5.3.5.3.5. Netherlands
          • 5.3.5.3.6. Rest of Europe
        • 5.3.5.4. MEA
          • 5.3.5.4.1. Middle East
          • 5.3.5.4.2. Africa
        • 5.3.5.5. North America
          • 5.3.5.5.1. United States
          • 5.3.5.5.2. Canada
          • 5.3.5.5.3. Mexico
    • 5.4. Global Neuroendoscopy (Price)
      • 5.4.1. Global Neuroendoscopy by: Type (Price)
  • 6. Neuroendoscopy: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. KARL STORZ (Germany)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. B. Braun (Germany)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Ackermann Instrumente (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Adeor Medical (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Hangzhou Hawk Optical Electronic Instruments (China)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Machida Endoscope (Japan)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Tonglu Wanhe Medical Instrument (China)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Schindler Endoskopie (Germany)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Clarus Medical (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. LocaMed (United Kingdom)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Neuroendoscopy Sale, by Type, Application, Usability, End User, Tumor Type and Region (value, volume and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Neuroendoscopy (Value)
      • 7.2.1. Global Neuroendoscopy by: Type (Value)
        • 7.2.1.1. Rigid Neuroendoscopes
        • 7.2.1.2. Flexible Neuroendoscopes
      • 7.2.2. Global Neuroendoscopy by: Application (Value)
        • 7.2.2.1. Transnasal
        • 7.2.2.2. Intraventricular
        • 7.2.2.3. Transcranial
      • 7.2.3. Global Neuroendoscopy by: Usability (Value)
        • 7.2.3.1. Reusable
        • 7.2.3.2. Disposable
      • 7.2.4. Global Neuroendoscopy by: End User (Value)
        • 7.2.4.1. Hospitals
        • 7.2.4.2. Surgical Centers
      • 7.2.5. Global Neuroendoscopy Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Neuroendoscopy (Volume)
      • 7.3.1. Global Neuroendoscopy by: Type (Volume)
        • 7.3.1.1. Rigid Neuroendoscopes
        • 7.3.1.2. Flexible Neuroendoscopes
      • 7.3.2. Global Neuroendoscopy by: Application (Volume)
        • 7.3.2.1. Transnasal
        • 7.3.2.2. Intraventricular
        • 7.3.2.3. Transcranial
      • 7.3.3. Global Neuroendoscopy by: Usability (Volume)
        • 7.3.3.1. Reusable
        • 7.3.3.2. Disposable
      • 7.3.4. Global Neuroendoscopy by: End User (Volume)
        • 7.3.4.1. Hospitals
        • 7.3.4.2. Surgical Centers
      • 7.3.5. Global Neuroendoscopy Region
        • 7.3.5.1. South America
          • 7.3.5.1.1. Brazil
          • 7.3.5.1.2. Argentina
          • 7.3.5.1.3. Rest of South America
        • 7.3.5.2. Asia Pacific
          • 7.3.5.2.1. China
          • 7.3.5.2.2. Japan
          • 7.3.5.2.3. India
          • 7.3.5.2.4. South Korea
          • 7.3.5.2.5. Taiwan
          • 7.3.5.2.6. Australia
          • 7.3.5.2.7. Rest of Asia-Pacific
        • 7.3.5.3. Europe
          • 7.3.5.3.1. Germany
          • 7.3.5.3.2. France
          • 7.3.5.3.3. Italy
          • 7.3.5.3.4. United Kingdom
          • 7.3.5.3.5. Netherlands
          • 7.3.5.3.6. Rest of Europe
        • 7.3.5.4. MEA
          • 7.3.5.4.1. Middle East
          • 7.3.5.4.2. Africa
        • 7.3.5.5. North America
          • 7.3.5.5.1. United States
          • 7.3.5.5.2. Canada
          • 7.3.5.5.3. Mexico
    • 7.4. Global Neuroendoscopy (Price)
      • 7.4.1. Global Neuroendoscopy by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Neuroendoscopy: by Type(USD Million)
  • Table 2. Neuroendoscopy Rigid Neuroendoscopes , by Region USD Million (2015-2020)
  • Table 3. Neuroendoscopy Flexible Neuroendoscopes , by Region USD Million (2015-2020)
  • Table 4. Neuroendoscopy: by Application(USD Million)
  • Table 5. Neuroendoscopy Transnasal , by Region USD Million (2015-2020)
  • Table 6. Neuroendoscopy Intraventricular , by Region USD Million (2015-2020)
  • Table 7. Neuroendoscopy Transcranial , by Region USD Million (2015-2020)
  • Table 8. Neuroendoscopy: by Usability(USD Million)
  • Table 9. Neuroendoscopy Reusable , by Region USD Million (2015-2020)
  • Table 10. Neuroendoscopy Disposable , by Region USD Million (2015-2020)
  • Table 11. Neuroendoscopy: by End User(USD Million)
  • Table 12. Neuroendoscopy Hospitals , by Region USD Million (2015-2020)
  • Table 13. Neuroendoscopy Surgical Centers , by Region USD Million (2015-2020)
  • Table 14. South America Neuroendoscopy, by Country USD Million (2015-2020)
  • Table 15. South America Neuroendoscopy, by Type USD Million (2015-2020)
  • Table 16. South America Neuroendoscopy, by Application USD Million (2015-2020)
  • Table 17. South America Neuroendoscopy, by Usability USD Million (2015-2020)
  • Table 18. South America Neuroendoscopy, by End User USD Million (2015-2020)
  • Table 19. South America Neuroendoscopy, by Tumor Type USD Million (2015-2020)
  • Table 20. Brazil Neuroendoscopy, by Type USD Million (2015-2020)
  • Table 21. Brazil Neuroendoscopy, by Application USD Million (2015-2020)
  • Table 22. Brazil Neuroendoscopy, by Usability USD Million (2015-2020)
  • Table 23. Brazil Neuroendoscopy, by End User USD Million (2015-2020)
  • Table 24. Brazil Neuroendoscopy, by Tumor Type USD Million (2015-2020)
  • Table 25. Argentina Neuroendoscopy, by Type USD Million (2015-2020)
  • Table 26. Argentina Neuroendoscopy, by Application USD Million (2015-2020)
  • Table 27. Argentina Neuroendoscopy, by Usability USD Million (2015-2020)
  • Table 28. Argentina Neuroendoscopy, by End User USD Million (2015-2020)
  • Table 29. Argentina Neuroendoscopy, by Tumor Type USD Million (2015-2020)
  • Table 30. Rest of South America Neuroendoscopy, by Type USD Million (2015-2020)
  • Table 31. Rest of South America Neuroendoscopy, by Application USD Million (2015-2020)
  • Table 32. Rest of South America Neuroendoscopy, by Usability USD Million (2015-2020)
  • Table 33. Rest of South America Neuroendoscopy, by End User USD Million (2015-2020)
  • Table 34. Rest of South America Neuroendoscopy, by Tumor Type USD Million (2015-2020)
  • Table 35. Asia Pacific Neuroendoscopy, by Country USD Million (2015-2020)
  • Table 36. Asia Pacific Neuroendoscopy, by Type USD Million (2015-2020)
  • Table 37. Asia Pacific Neuroendoscopy, by Application USD Million (2015-2020)
  • Table 38. Asia Pacific Neuroendoscopy, by Usability USD Million (2015-2020)
  • Table 39. Asia Pacific Neuroendoscopy, by End User USD Million (2015-2020)
  • Table 40. Asia Pacific Neuroendoscopy, by Tumor Type USD Million (2015-2020)
  • Table 41. China Neuroendoscopy, by Type USD Million (2015-2020)
  • Table 42. China Neuroendoscopy, by Application USD Million (2015-2020)
  • Table 43. China Neuroendoscopy, by Usability USD Million (2015-2020)
  • Table 44. China Neuroendoscopy, by End User USD Million (2015-2020)
  • Table 45. China Neuroendoscopy, by Tumor Type USD Million (2015-2020)
  • Table 46. Japan Neuroendoscopy, by Type USD Million (2015-2020)
  • Table 47. Japan Neuroendoscopy, by Application USD Million (2015-2020)
  • Table 48. Japan Neuroendoscopy, by Usability USD Million (2015-2020)
  • Table 49. Japan Neuroendoscopy, by End User USD Million (2015-2020)
  • Table 50. Japan Neuroendoscopy, by Tumor Type USD Million (2015-2020)
  • Table 51. India Neuroendoscopy, by Type USD Million (2015-2020)
  • Table 52. India Neuroendoscopy, by Application USD Million (2015-2020)
  • Table 53. India Neuroendoscopy, by Usability USD Million (2015-2020)
  • Table 54. India Neuroendoscopy, by End User USD Million (2015-2020)
  • Table 55. India Neuroendoscopy, by Tumor Type USD Million (2015-2020)
  • Table 56. South Korea Neuroendoscopy, by Type USD Million (2015-2020)
  • Table 57. South Korea Neuroendoscopy, by Application USD Million (2015-2020)
  • Table 58. South Korea Neuroendoscopy, by Usability USD Million (2015-2020)
  • Table 59. South Korea Neuroendoscopy, by End User USD Million (2015-2020)
  • Table 60. South Korea Neuroendoscopy, by Tumor Type USD Million (2015-2020)
  • Table 61. Taiwan Neuroendoscopy, by Type USD Million (2015-2020)
  • Table 62. Taiwan Neuroendoscopy, by Application USD Million (2015-2020)
  • Table 63. Taiwan Neuroendoscopy, by Usability USD Million (2015-2020)
  • Table 64. Taiwan Neuroendoscopy, by End User USD Million (2015-2020)
  • Table 65. Taiwan Neuroendoscopy, by Tumor Type USD Million (2015-2020)
  • Table 66. Australia Neuroendoscopy, by Type USD Million (2015-2020)
  • Table 67. Australia Neuroendoscopy, by Application USD Million (2015-2020)
  • Table 68. Australia Neuroendoscopy, by Usability USD Million (2015-2020)
  • Table 69. Australia Neuroendoscopy, by End User USD Million (2015-2020)
  • Table 70. Australia Neuroendoscopy, by Tumor Type USD Million (2015-2020)
  • Table 71. Rest of Asia-Pacific Neuroendoscopy, by Type USD Million (2015-2020)
  • Table 72. Rest of Asia-Pacific Neuroendoscopy, by Application USD Million (2015-2020)
  • Table 73. Rest of Asia-Pacific Neuroendoscopy, by Usability USD Million (2015-2020)
  • Table 74. Rest of Asia-Pacific Neuroendoscopy, by End User USD Million (2015-2020)
  • Table 75. Rest of Asia-Pacific Neuroendoscopy, by Tumor Type USD Million (2015-2020)
  • Table 76. Europe Neuroendoscopy, by Country USD Million (2015-2020)
  • Table 77. Europe Neuroendoscopy, by Type USD Million (2015-2020)
  • Table 78. Europe Neuroendoscopy, by Application USD Million (2015-2020)
  • Table 79. Europe Neuroendoscopy, by Usability USD Million (2015-2020)
  • Table 80. Europe Neuroendoscopy, by End User USD Million (2015-2020)
  • Table 81. Europe Neuroendoscopy, by Tumor Type USD Million (2015-2020)
  • Table 82. Germany Neuroendoscopy, by Type USD Million (2015-2020)
  • Table 83. Germany Neuroendoscopy, by Application USD Million (2015-2020)
  • Table 84. Germany Neuroendoscopy, by Usability USD Million (2015-2020)
  • Table 85. Germany Neuroendoscopy, by End User USD Million (2015-2020)
  • Table 86. Germany Neuroendoscopy, by Tumor Type USD Million (2015-2020)
  • Table 87. France Neuroendoscopy, by Type USD Million (2015-2020)
  • Table 88. France Neuroendoscopy, by Application USD Million (2015-2020)
  • Table 89. France Neuroendoscopy, by Usability USD Million (2015-2020)
  • Table 90. France Neuroendoscopy, by End User USD Million (2015-2020)
  • Table 91. France Neuroendoscopy, by Tumor Type USD Million (2015-2020)
  • Table 92. Italy Neuroendoscopy, by Type USD Million (2015-2020)
  • Table 93. Italy Neuroendoscopy, by Application USD Million (2015-2020)
  • Table 94. Italy Neuroendoscopy, by Usability USD Million (2015-2020)
  • Table 95. Italy Neuroendoscopy, by End User USD Million (2015-2020)
  • Table 96. Italy Neuroendoscopy, by Tumor Type USD Million (2015-2020)
  • Table 97. United Kingdom Neuroendoscopy, by Type USD Million (2015-2020)
  • Table 98. United Kingdom Neuroendoscopy, by Application USD Million (2015-2020)
  • Table 99. United Kingdom Neuroendoscopy, by Usability USD Million (2015-2020)
  • Table 100. United Kingdom Neuroendoscopy, by End User USD Million (2015-2020)
  • Table 101. United Kingdom Neuroendoscopy, by Tumor Type USD Million (2015-2020)
  • Table 102. Netherlands Neuroendoscopy, by Type USD Million (2015-2020)
  • Table 103. Netherlands Neuroendoscopy, by Application USD Million (2015-2020)
  • Table 104. Netherlands Neuroendoscopy, by Usability USD Million (2015-2020)
  • Table 105. Netherlands Neuroendoscopy, by End User USD Million (2015-2020)
  • Table 106. Netherlands Neuroendoscopy, by Tumor Type USD Million (2015-2020)
  • Table 107. Rest of Europe Neuroendoscopy, by Type USD Million (2015-2020)
  • Table 108. Rest of Europe Neuroendoscopy, by Application USD Million (2015-2020)
  • Table 109. Rest of Europe Neuroendoscopy, by Usability USD Million (2015-2020)
  • Table 110. Rest of Europe Neuroendoscopy, by End User USD Million (2015-2020)
  • Table 111. Rest of Europe Neuroendoscopy, by Tumor Type USD Million (2015-2020)
  • Table 112. MEA Neuroendoscopy, by Country USD Million (2015-2020)
  • Table 113. MEA Neuroendoscopy, by Type USD Million (2015-2020)
  • Table 114. MEA Neuroendoscopy, by Application USD Million (2015-2020)
  • Table 115. MEA Neuroendoscopy, by Usability USD Million (2015-2020)
  • Table 116. MEA Neuroendoscopy, by End User USD Million (2015-2020)
  • Table 117. MEA Neuroendoscopy, by Tumor Type USD Million (2015-2020)
  • Table 118. Middle East Neuroendoscopy, by Type USD Million (2015-2020)
  • Table 119. Middle East Neuroendoscopy, by Application USD Million (2015-2020)
  • Table 120. Middle East Neuroendoscopy, by Usability USD Million (2015-2020)
  • Table 121. Middle East Neuroendoscopy, by End User USD Million (2015-2020)
  • Table 122. Middle East Neuroendoscopy, by Tumor Type USD Million (2015-2020)
  • Table 123. Africa Neuroendoscopy, by Type USD Million (2015-2020)
  • Table 124. Africa Neuroendoscopy, by Application USD Million (2015-2020)
  • Table 125. Africa Neuroendoscopy, by Usability USD Million (2015-2020)
  • Table 126. Africa Neuroendoscopy, by End User USD Million (2015-2020)
  • Table 127. Africa Neuroendoscopy, by Tumor Type USD Million (2015-2020)
  • Table 128. North America Neuroendoscopy, by Country USD Million (2015-2020)
  • Table 129. North America Neuroendoscopy, by Type USD Million (2015-2020)
  • Table 130. North America Neuroendoscopy, by Application USD Million (2015-2020)
  • Table 131. North America Neuroendoscopy, by Usability USD Million (2015-2020)
  • Table 132. North America Neuroendoscopy, by End User USD Million (2015-2020)
  • Table 133. North America Neuroendoscopy, by Tumor Type USD Million (2015-2020)
  • Table 134. United States Neuroendoscopy, by Type USD Million (2015-2020)
  • Table 135. United States Neuroendoscopy, by Application USD Million (2015-2020)
  • Table 136. United States Neuroendoscopy, by Usability USD Million (2015-2020)
  • Table 137. United States Neuroendoscopy, by End User USD Million (2015-2020)
  • Table 138. United States Neuroendoscopy, by Tumor Type USD Million (2015-2020)
  • Table 139. Canada Neuroendoscopy, by Type USD Million (2015-2020)
  • Table 140. Canada Neuroendoscopy, by Application USD Million (2015-2020)
  • Table 141. Canada Neuroendoscopy, by Usability USD Million (2015-2020)
  • Table 142. Canada Neuroendoscopy, by End User USD Million (2015-2020)
  • Table 143. Canada Neuroendoscopy, by Tumor Type USD Million (2015-2020)
  • Table 144. Mexico Neuroendoscopy, by Type USD Million (2015-2020)
  • Table 145. Mexico Neuroendoscopy, by Application USD Million (2015-2020)
  • Table 146. Mexico Neuroendoscopy, by Usability USD Million (2015-2020)
  • Table 147. Mexico Neuroendoscopy, by End User USD Million (2015-2020)
  • Table 148. Mexico Neuroendoscopy, by Tumor Type USD Million (2015-2020)
  • Table 149. Neuroendoscopy Sales: by Type(K Units)
  • Table 150. Neuroendoscopy Sales Rigid Neuroendoscopes , by Region K Units (2015-2020)
  • Table 151. Neuroendoscopy Sales Flexible Neuroendoscopes , by Region K Units (2015-2020)
  • Table 152. Neuroendoscopy Sales: by Application(K Units)
  • Table 153. Neuroendoscopy Sales Transnasal , by Region K Units (2015-2020)
  • Table 154. Neuroendoscopy Sales Intraventricular , by Region K Units (2015-2020)
  • Table 155. Neuroendoscopy Sales Transcranial , by Region K Units (2015-2020)
  • Table 156. Neuroendoscopy Sales: by Usability(K Units)
  • Table 157. Neuroendoscopy Sales Reusable , by Region K Units (2015-2020)
  • Table 158. Neuroendoscopy Sales Disposable , by Region K Units (2015-2020)
  • Table 159. Neuroendoscopy Sales: by End User(K Units)
  • Table 160. Neuroendoscopy Sales Hospitals , by Region K Units (2015-2020)
  • Table 161. Neuroendoscopy Sales Surgical Centers , by Region K Units (2015-2020)
  • Table 162. South America Neuroendoscopy Sales, by Country K Units (2015-2020)
  • Table 163. South America Neuroendoscopy Sales, by Type K Units (2015-2020)
  • Table 164. South America Neuroendoscopy Sales, by Application K Units (2015-2020)
  • Table 165. South America Neuroendoscopy Sales, by Usability K Units (2015-2020)
  • Table 166. South America Neuroendoscopy Sales, by End User K Units (2015-2020)
  • Table 167. South America Neuroendoscopy Sales, by Tumor Type K Units (2015-2020)
  • Table 168. Brazil Neuroendoscopy Sales, by Type K Units (2015-2020)
  • Table 169. Brazil Neuroendoscopy Sales, by Application K Units (2015-2020)
  • Table 170. Brazil Neuroendoscopy Sales, by Usability K Units (2015-2020)
  • Table 171. Brazil Neuroendoscopy Sales, by End User K Units (2015-2020)
  • Table 172. Brazil Neuroendoscopy Sales, by Tumor Type K Units (2015-2020)
  • Table 173. Argentina Neuroendoscopy Sales, by Type K Units (2015-2020)
  • Table 174. Argentina Neuroendoscopy Sales, by Application K Units (2015-2020)
  • Table 175. Argentina Neuroendoscopy Sales, by Usability K Units (2015-2020)
  • Table 176. Argentina Neuroendoscopy Sales, by End User K Units (2015-2020)
  • Table 177. Argentina Neuroendoscopy Sales, by Tumor Type K Units (2015-2020)
  • Table 178. Rest of South America Neuroendoscopy Sales, by Type K Units (2015-2020)
  • Table 179. Rest of South America Neuroendoscopy Sales, by Application K Units (2015-2020)
  • Table 180. Rest of South America Neuroendoscopy Sales, by Usability K Units (2015-2020)
  • Table 181. Rest of South America Neuroendoscopy Sales, by End User K Units (2015-2020)
  • Table 182. Rest of South America Neuroendoscopy Sales, by Tumor Type K Units (2015-2020)
  • Table 183. Asia Pacific Neuroendoscopy Sales, by Country K Units (2015-2020)
  • Table 184. Asia Pacific Neuroendoscopy Sales, by Type K Units (2015-2020)
  • Table 185. Asia Pacific Neuroendoscopy Sales, by Application K Units (2015-2020)
  • Table 186. Asia Pacific Neuroendoscopy Sales, by Usability K Units (2015-2020)
  • Table 187. Asia Pacific Neuroendoscopy Sales, by End User K Units (2015-2020)
  • Table 188. Asia Pacific Neuroendoscopy Sales, by Tumor Type K Units (2015-2020)
  • Table 189. China Neuroendoscopy Sales, by Type K Units (2015-2020)
  • Table 190. China Neuroendoscopy Sales, by Application K Units (2015-2020)
  • Table 191. China Neuroendoscopy Sales, by Usability K Units (2015-2020)
  • Table 192. China Neuroendoscopy Sales, by End User K Units (2015-2020)
  • Table 193. China Neuroendoscopy Sales, by Tumor Type K Units (2015-2020)
  • Table 194. Japan Neuroendoscopy Sales, by Type K Units (2015-2020)
  • Table 195. Japan Neuroendoscopy Sales, by Application K Units (2015-2020)
  • Table 196. Japan Neuroendoscopy Sales, by Usability K Units (2015-2020)
  • Table 197. Japan Neuroendoscopy Sales, by End User K Units (2015-2020)
  • Table 198. Japan Neuroendoscopy Sales, by Tumor Type K Units (2015-2020)
  • Table 199. India Neuroendoscopy Sales, by Type K Units (2015-2020)
  • Table 200. India Neuroendoscopy Sales, by Application K Units (2015-2020)
  • Table 201. India Neuroendoscopy Sales, by Usability K Units (2015-2020)
  • Table 202. India Neuroendoscopy Sales, by End User K Units (2015-2020)
  • Table 203. India Neuroendoscopy Sales, by Tumor Type K Units (2015-2020)
  • Table 204. South Korea Neuroendoscopy Sales, by Type K Units (2015-2020)
  • Table 205. South Korea Neuroendoscopy Sales, by Application K Units (2015-2020)
  • Table 206. South Korea Neuroendoscopy Sales, by Usability K Units (2015-2020)
  • Table 207. South Korea Neuroendoscopy Sales, by End User K Units (2015-2020)
  • Table 208. South Korea Neuroendoscopy Sales, by Tumor Type K Units (2015-2020)
  • Table 209. Taiwan Neuroendoscopy Sales, by Type K Units (2015-2020)
  • Table 210. Taiwan Neuroendoscopy Sales, by Application K Units (2015-2020)
  • Table 211. Taiwan Neuroendoscopy Sales, by Usability K Units (2015-2020)
  • Table 212. Taiwan Neuroendoscopy Sales, by End User K Units (2015-2020)
  • Table 213. Taiwan Neuroendoscopy Sales, by Tumor Type K Units (2015-2020)
  • Table 214. Australia Neuroendoscopy Sales, by Type K Units (2015-2020)
  • Table 215. Australia Neuroendoscopy Sales, by Application K Units (2015-2020)
  • Table 216. Australia Neuroendoscopy Sales, by Usability K Units (2015-2020)
  • Table 217. Australia Neuroendoscopy Sales, by End User K Units (2015-2020)
  • Table 218. Australia Neuroendoscopy Sales, by Tumor Type K Units (2015-2020)
  • Table 219. Rest of Asia-Pacific Neuroendoscopy Sales, by Type K Units (2015-2020)
  • Table 220. Rest of Asia-Pacific Neuroendoscopy Sales, by Application K Units (2015-2020)
  • Table 221. Rest of Asia-Pacific Neuroendoscopy Sales, by Usability K Units (2015-2020)
  • Table 222. Rest of Asia-Pacific Neuroendoscopy Sales, by End User K Units (2015-2020)
  • Table 223. Rest of Asia-Pacific Neuroendoscopy Sales, by Tumor Type K Units (2015-2020)
  • Table 224. Europe Neuroendoscopy Sales, by Country K Units (2015-2020)
  • Table 225. Europe Neuroendoscopy Sales, by Type K Units (2015-2020)
  • Table 226. Europe Neuroendoscopy Sales, by Application K Units (2015-2020)
  • Table 227. Europe Neuroendoscopy Sales, by Usability K Units (2015-2020)
  • Table 228. Europe Neuroendoscopy Sales, by End User K Units (2015-2020)
  • Table 229. Europe Neuroendoscopy Sales, by Tumor Type K Units (2015-2020)
  • Table 230. Germany Neuroendoscopy Sales, by Type K Units (2015-2020)
  • Table 231. Germany Neuroendoscopy Sales, by Application K Units (2015-2020)
  • Table 232. Germany Neuroendoscopy Sales, by Usability K Units (2015-2020)
  • Table 233. Germany Neuroendoscopy Sales, by End User K Units (2015-2020)
  • Table 234. Germany Neuroendoscopy Sales, by Tumor Type K Units (2015-2020)
  • Table 235. France Neuroendoscopy Sales, by Type K Units (2015-2020)
  • Table 236. France Neuroendoscopy Sales, by Application K Units (2015-2020)
  • Table 237. France Neuroendoscopy Sales, by Usability K Units (2015-2020)
  • Table 238. France Neuroendoscopy Sales, by End User K Units (2015-2020)
  • Table 239. France Neuroendoscopy Sales, by Tumor Type K Units (2015-2020)
  • Table 240. Italy Neuroendoscopy Sales, by Type K Units (2015-2020)
  • Table 241. Italy Neuroendoscopy Sales, by Application K Units (2015-2020)
  • Table 242. Italy Neuroendoscopy Sales, by Usability K Units (2015-2020)
  • Table 243. Italy Neuroendoscopy Sales, by End User K Units (2015-2020)
  • Table 244. Italy Neuroendoscopy Sales, by Tumor Type K Units (2015-2020)
  • Table 245. United Kingdom Neuroendoscopy Sales, by Type K Units (2015-2020)
  • Table 246. United Kingdom Neuroendoscopy Sales, by Application K Units (2015-2020)
  • Table 247. United Kingdom Neuroendoscopy Sales, by Usability K Units (2015-2020)
  • Table 248. United Kingdom Neuroendoscopy Sales, by End User K Units (2015-2020)
  • Table 249. United Kingdom Neuroendoscopy Sales, by Tumor Type K Units (2015-2020)
  • Table 250. Netherlands Neuroendoscopy Sales, by Type K Units (2015-2020)
  • Table 251. Netherlands Neuroendoscopy Sales, by Application K Units (2015-2020)
  • Table 252. Netherlands Neuroendoscopy Sales, by Usability K Units (2015-2020)
  • Table 253. Netherlands Neuroendoscopy Sales, by End User K Units (2015-2020)
  • Table 254. Netherlands Neuroendoscopy Sales, by Tumor Type K Units (2015-2020)
  • Table 255. Rest of Europe Neuroendoscopy Sales, by Type K Units (2015-2020)
  • Table 256. Rest of Europe Neuroendoscopy Sales, by Application K Units (2015-2020)
  • Table 257. Rest of Europe Neuroendoscopy Sales, by Usability K Units (2015-2020)
  • Table 258. Rest of Europe Neuroendoscopy Sales, by End User K Units (2015-2020)
  • Table 259. Rest of Europe Neuroendoscopy Sales, by Tumor Type K Units (2015-2020)
  • Table 260. MEA Neuroendoscopy Sales, by Country K Units (2015-2020)
  • Table 261. MEA Neuroendoscopy Sales, by Type K Units (2015-2020)
  • Table 262. MEA Neuroendoscopy Sales, by Application K Units (2015-2020)
  • Table 263. MEA Neuroendoscopy Sales, by Usability K Units (2015-2020)
  • Table 264. MEA Neuroendoscopy Sales, by End User K Units (2015-2020)
  • Table 265. MEA Neuroendoscopy Sales, by Tumor Type K Units (2015-2020)
  • Table 266. Middle East Neuroendoscopy Sales, by Type K Units (2015-2020)
  • Table 267. Middle East Neuroendoscopy Sales, by Application K Units (2015-2020)
  • Table 268. Middle East Neuroendoscopy Sales, by Usability K Units (2015-2020)
  • Table 269. Middle East Neuroendoscopy Sales, by End User K Units (2015-2020)
  • Table 270. Middle East Neuroendoscopy Sales, by Tumor Type K Units (2015-2020)
  • Table 271. Africa Neuroendoscopy Sales, by Type K Units (2015-2020)
  • Table 272. Africa Neuroendoscopy Sales, by Application K Units (2015-2020)
  • Table 273. Africa Neuroendoscopy Sales, by Usability K Units (2015-2020)
  • Table 274. Africa Neuroendoscopy Sales, by End User K Units (2015-2020)
  • Table 275. Africa Neuroendoscopy Sales, by Tumor Type K Units (2015-2020)
  • Table 276. North America Neuroendoscopy Sales, by Country K Units (2015-2020)
  • Table 277. North America Neuroendoscopy Sales, by Type K Units (2015-2020)
  • Table 278. North America Neuroendoscopy Sales, by Application K Units (2015-2020)
  • Table 279. North America Neuroendoscopy Sales, by Usability K Units (2015-2020)
  • Table 280. North America Neuroendoscopy Sales, by End User K Units (2015-2020)
  • Table 281. North America Neuroendoscopy Sales, by Tumor Type K Units (2015-2020)
  • Table 282. United States Neuroendoscopy Sales, by Type K Units (2015-2020)
  • Table 283. United States Neuroendoscopy Sales, by Application K Units (2015-2020)
  • Table 284. United States Neuroendoscopy Sales, by Usability K Units (2015-2020)
  • Table 285. United States Neuroendoscopy Sales, by End User K Units (2015-2020)
  • Table 286. United States Neuroendoscopy Sales, by Tumor Type K Units (2015-2020)
  • Table 287. Canada Neuroendoscopy Sales, by Type K Units (2015-2020)
  • Table 288. Canada Neuroendoscopy Sales, by Application K Units (2015-2020)
  • Table 289. Canada Neuroendoscopy Sales, by Usability K Units (2015-2020)
  • Table 290. Canada Neuroendoscopy Sales, by End User K Units (2015-2020)
  • Table 291. Canada Neuroendoscopy Sales, by Tumor Type K Units (2015-2020)
  • Table 292. Mexico Neuroendoscopy Sales, by Type K Units (2015-2020)
  • Table 293. Mexico Neuroendoscopy Sales, by Application K Units (2015-2020)
  • Table 294. Mexico Neuroendoscopy Sales, by Usability K Units (2015-2020)
  • Table 295. Mexico Neuroendoscopy Sales, by End User K Units (2015-2020)
  • Table 296. Mexico Neuroendoscopy Sales, by Tumor Type K Units (2015-2020)
  • Table 297. Neuroendoscopy: by Type(USD/Units)
  • Table 298. Company Basic Information, Sales Area and Its Competitors
  • Table 299. Company Basic Information, Sales Area and Its Competitors
  • Table 300. Company Basic Information, Sales Area and Its Competitors
  • Table 301. Company Basic Information, Sales Area and Its Competitors
  • Table 302. Company Basic Information, Sales Area and Its Competitors
  • Table 303. Company Basic Information, Sales Area and Its Competitors
  • Table 304. Company Basic Information, Sales Area and Its Competitors
  • Table 305. Company Basic Information, Sales Area and Its Competitors
  • Table 306. Company Basic Information, Sales Area and Its Competitors
  • Table 307. Company Basic Information, Sales Area and Its Competitors
  • Table 308. Neuroendoscopy: by Type(USD Million)
  • Table 309. Neuroendoscopy Rigid Neuroendoscopes , by Region USD Million (2021-2026)
  • Table 310. Neuroendoscopy Flexible Neuroendoscopes , by Region USD Million (2021-2026)
  • Table 311. Neuroendoscopy: by Application(USD Million)
  • Table 312. Neuroendoscopy Transnasal , by Region USD Million (2021-2026)
  • Table 313. Neuroendoscopy Intraventricular , by Region USD Million (2021-2026)
  • Table 314. Neuroendoscopy Transcranial , by Region USD Million (2021-2026)
  • Table 315. Neuroendoscopy: by Usability(USD Million)
  • Table 316. Neuroendoscopy Reusable , by Region USD Million (2021-2026)
  • Table 317. Neuroendoscopy Disposable , by Region USD Million (2021-2026)
  • Table 318. Neuroendoscopy: by End User(USD Million)
  • Table 319. Neuroendoscopy Hospitals , by Region USD Million (2021-2026)
  • Table 320. Neuroendoscopy Surgical Centers , by Region USD Million (2021-2026)
  • Table 321. South America Neuroendoscopy, by Country USD Million (2021-2026)
  • Table 322. South America Neuroendoscopy, by Type USD Million (2021-2026)
  • Table 323. South America Neuroendoscopy, by Application USD Million (2021-2026)
  • Table 324. South America Neuroendoscopy, by Usability USD Million (2021-2026)
  • Table 325. South America Neuroendoscopy, by End User USD Million (2021-2026)
  • Table 326. South America Neuroendoscopy, by Tumor Type USD Million (2021-2026)
  • Table 327. Brazil Neuroendoscopy, by Type USD Million (2021-2026)
  • Table 328. Brazil Neuroendoscopy, by Application USD Million (2021-2026)
  • Table 329. Brazil Neuroendoscopy, by Usability USD Million (2021-2026)
  • Table 330. Brazil Neuroendoscopy, by End User USD Million (2021-2026)
  • Table 331. Brazil Neuroendoscopy, by Tumor Type USD Million (2021-2026)
  • Table 332. Argentina Neuroendoscopy, by Type USD Million (2021-2026)
  • Table 333. Argentina Neuroendoscopy, by Application USD Million (2021-2026)
  • Table 334. Argentina Neuroendoscopy, by Usability USD Million (2021-2026)
  • Table 335. Argentina Neuroendoscopy, by End User USD Million (2021-2026)
  • Table 336. Argentina Neuroendoscopy, by Tumor Type USD Million (2021-2026)
  • Table 337. Rest of South America Neuroendoscopy, by Type USD Million (2021-2026)
  • Table 338. Rest of South America Neuroendoscopy, by Application USD Million (2021-2026)
  • Table 339. Rest of South America Neuroendoscopy, by Usability USD Million (2021-2026)
  • Table 340. Rest of South America Neuroendoscopy, by End User USD Million (2021-2026)
  • Table 341. Rest of South America Neuroendoscopy, by Tumor Type USD Million (2021-2026)
  • Table 342. Asia Pacific Neuroendoscopy, by Country USD Million (2021-2026)
  • Table 343. Asia Pacific Neuroendoscopy, by Type USD Million (2021-2026)
  • Table 344. Asia Pacific Neuroendoscopy, by Application USD Million (2021-2026)
  • Table 345. Asia Pacific Neuroendoscopy, by Usability USD Million (2021-2026)
  • Table 346. Asia Pacific Neuroendoscopy, by End User USD Million (2021-2026)
  • Table 347. Asia Pacific Neuroendoscopy, by Tumor Type USD Million (2021-2026)
  • Table 348. China Neuroendoscopy, by Type USD Million (2021-2026)
  • Table 349. China Neuroendoscopy, by Application USD Million (2021-2026)
  • Table 350. China Neuroendoscopy, by Usability USD Million (2021-2026)
  • Table 351. China Neuroendoscopy, by End User USD Million (2021-2026)
  • Table 352. China Neuroendoscopy, by Tumor Type USD Million (2021-2026)
  • Table 353. Japan Neuroendoscopy, by Type USD Million (2021-2026)
  • Table 354. Japan Neuroendoscopy, by Application USD Million (2021-2026)
  • Table 355. Japan Neuroendoscopy, by Usability USD Million (2021-2026)
  • Table 356. Japan Neuroendoscopy, by End User USD Million (2021-2026)
  • Table 357. Japan Neuroendoscopy, by Tumor Type USD Million (2021-2026)
  • Table 358. India Neuroendoscopy, by Type USD Million (2021-2026)
  • Table 359. India Neuroendoscopy, by Application USD Million (2021-2026)
  • Table 360. India Neuroendoscopy, by Usability USD Million (2021-2026)
  • Table 361. India Neuroendoscopy, by End User USD Million (2021-2026)
  • Table 362. India Neuroendoscopy, by Tumor Type USD Million (2021-2026)
  • Table 363. South Korea Neuroendoscopy, by Type USD Million (2021-2026)
  • Table 364. South Korea Neuroendoscopy, by Application USD Million (2021-2026)
  • Table 365. South Korea Neuroendoscopy, by Usability USD Million (2021-2026)
  • Table 366. South Korea Neuroendoscopy, by End User USD Million (2021-2026)
  • Table 367. South Korea Neuroendoscopy, by Tumor Type USD Million (2021-2026)
  • Table 368. Taiwan Neuroendoscopy, by Type USD Million (2021-2026)
  • Table 369. Taiwan Neuroendoscopy, by Application USD Million (2021-2026)
  • Table 370. Taiwan Neuroendoscopy, by Usability USD Million (2021-2026)
  • Table 371. Taiwan Neuroendoscopy, by End User USD Million (2021-2026)
  • Table 372. Taiwan Neuroendoscopy, by Tumor Type USD Million (2021-2026)
  • Table 373. Australia Neuroendoscopy, by Type USD Million (2021-2026)
  • Table 374. Australia Neuroendoscopy, by Application USD Million (2021-2026)
  • Table 375. Australia Neuroendoscopy, by Usability USD Million (2021-2026)
  • Table 376. Australia Neuroendoscopy, by End User USD Million (2021-2026)
  • Table 377. Australia Neuroendoscopy, by Tumor Type USD Million (2021-2026)
  • Table 378. Rest of Asia-Pacific Neuroendoscopy, by Type USD Million (2021-2026)
  • Table 379. Rest of Asia-Pacific Neuroendoscopy, by Application USD Million (2021-2026)
  • Table 380. Rest of Asia-Pacific Neuroendoscopy, by Usability USD Million (2021-2026)
  • Table 381. Rest of Asia-Pacific Neuroendoscopy, by End User USD Million (2021-2026)
  • Table 382. Rest of Asia-Pacific Neuroendoscopy, by Tumor Type USD Million (2021-2026)
  • Table 383. Europe Neuroendoscopy, by Country USD Million (2021-2026)
  • Table 384. Europe Neuroendoscopy, by Type USD Million (2021-2026)
  • Table 385. Europe Neuroendoscopy, by Application USD Million (2021-2026)
  • Table 386. Europe Neuroendoscopy, by Usability USD Million (2021-2026)
  • Table 387. Europe Neuroendoscopy, by End User USD Million (2021-2026)
  • Table 388. Europe Neuroendoscopy, by Tumor Type USD Million (2021-2026)
  • Table 389. Germany Neuroendoscopy, by Type USD Million (2021-2026)
  • Table 390. Germany Neuroendoscopy, by Application USD Million (2021-2026)
  • Table 391. Germany Neuroendoscopy, by Usability USD Million (2021-2026)
  • Table 392. Germany Neuroendoscopy, by End User USD Million (2021-2026)
  • Table 393. Germany Neuroendoscopy, by Tumor Type USD Million (2021-2026)
  • Table 394. France Neuroendoscopy, by Type USD Million (2021-2026)
  • Table 395. France Neuroendoscopy, by Application USD Million (2021-2026)
  • Table 396. France Neuroendoscopy, by Usability USD Million (2021-2026)
  • Table 397. France Neuroendoscopy, by End User USD Million (2021-2026)
  • Table 398. France Neuroendoscopy, by Tumor Type USD Million (2021-2026)
  • Table 399. Italy Neuroendoscopy, by Type USD Million (2021-2026)
  • Table 400. Italy Neuroendoscopy, by Application USD Million (2021-2026)
  • Table 401. Italy Neuroendoscopy, by Usability USD Million (2021-2026)
  • Table 402. Italy Neuroendoscopy, by End User USD Million (2021-2026)
  • Table 403. Italy Neuroendoscopy, by Tumor Type USD Million (2021-2026)
  • Table 404. United Kingdom Neuroendoscopy, by Type USD Million (2021-2026)
  • Table 405. United Kingdom Neuroendoscopy, by Application USD Million (2021-2026)
  • Table 406. United Kingdom Neuroendoscopy, by Usability USD Million (2021-2026)
  • Table 407. United Kingdom Neuroendoscopy, by End User USD Million (2021-2026)
  • Table 408. United Kingdom Neuroendoscopy, by Tumor Type USD Million (2021-2026)
  • Table 409. Netherlands Neuroendoscopy, by Type USD Million (2021-2026)
  • Table 410. Netherlands Neuroendoscopy, by Application USD Million (2021-2026)
  • Table 411. Netherlands Neuroendoscopy, by Usability USD Million (2021-2026)
  • Table 412. Netherlands Neuroendoscopy, by End User USD Million (2021-2026)
  • Table 413. Netherlands Neuroendoscopy, by Tumor Type USD Million (2021-2026)
  • Table 414. Rest of Europe Neuroendoscopy, by Type USD Million (2021-2026)
  • Table 415. Rest of Europe Neuroendoscopy, by Application USD Million (2021-2026)
  • Table 416. Rest of Europe Neuroendoscopy, by Usability USD Million (2021-2026)
  • Table 417. Rest of Europe Neuroendoscopy, by End User USD Million (2021-2026)
  • Table 418. Rest of Europe Neuroendoscopy, by Tumor Type USD Million (2021-2026)
  • Table 419. MEA Neuroendoscopy, by Country USD Million (2021-2026)
  • Table 420. MEA Neuroendoscopy, by Type USD Million (2021-2026)
  • Table 421. MEA Neuroendoscopy, by Application USD Million (2021-2026)
  • Table 422. MEA Neuroendoscopy, by Usability USD Million (2021-2026)
  • Table 423. MEA Neuroendoscopy, by End User USD Million (2021-2026)
  • Table 424. MEA Neuroendoscopy, by Tumor Type USD Million (2021-2026)
  • Table 425. Middle East Neuroendoscopy, by Type USD Million (2021-2026)
  • Table 426. Middle East Neuroendoscopy, by Application USD Million (2021-2026)
  • Table 427. Middle East Neuroendoscopy, by Usability USD Million (2021-2026)
  • Table 428. Middle East Neuroendoscopy, by End User USD Million (2021-2026)
  • Table 429. Middle East Neuroendoscopy, by Tumor Type USD Million (2021-2026)
  • Table 430. Africa Neuroendoscopy, by Type USD Million (2021-2026)
  • Table 431. Africa Neuroendoscopy, by Application USD Million (2021-2026)
  • Table 432. Africa Neuroendoscopy, by Usability USD Million (2021-2026)
  • Table 433. Africa Neuroendoscopy, by End User USD Million (2021-2026)
  • Table 434. Africa Neuroendoscopy, by Tumor Type USD Million (2021-2026)
  • Table 435. North America Neuroendoscopy, by Country USD Million (2021-2026)
  • Table 436. North America Neuroendoscopy, by Type USD Million (2021-2026)
  • Table 437. North America Neuroendoscopy, by Application USD Million (2021-2026)
  • Table 438. North America Neuroendoscopy, by Usability USD Million (2021-2026)
  • Table 439. North America Neuroendoscopy, by End User USD Million (2021-2026)
  • Table 440. North America Neuroendoscopy, by Tumor Type USD Million (2021-2026)
  • Table 441. United States Neuroendoscopy, by Type USD Million (2021-2026)
  • Table 442. United States Neuroendoscopy, by Application USD Million (2021-2026)
  • Table 443. United States Neuroendoscopy, by Usability USD Million (2021-2026)
  • Table 444. United States Neuroendoscopy, by End User USD Million (2021-2026)
  • Table 445. United States Neuroendoscopy, by Tumor Type USD Million (2021-2026)
  • Table 446. Canada Neuroendoscopy, by Type USD Million (2021-2026)
  • Table 447. Canada Neuroendoscopy, by Application USD Million (2021-2026)
  • Table 448. Canada Neuroendoscopy, by Usability USD Million (2021-2026)
  • Table 449. Canada Neuroendoscopy, by End User USD Million (2021-2026)
  • Table 450. Canada Neuroendoscopy, by Tumor Type USD Million (2021-2026)
  • Table 451. Mexico Neuroendoscopy, by Type USD Million (2021-2026)
  • Table 452. Mexico Neuroendoscopy, by Application USD Million (2021-2026)
  • Table 453. Mexico Neuroendoscopy, by Usability USD Million (2021-2026)
  • Table 454. Mexico Neuroendoscopy, by End User USD Million (2021-2026)
  • Table 455. Mexico Neuroendoscopy, by Tumor Type USD Million (2021-2026)
  • Table 456. Neuroendoscopy Sales: by Type(K Units)
  • Table 457. Neuroendoscopy Sales Rigid Neuroendoscopes , by Region K Units (2021-2026)
  • Table 458. Neuroendoscopy Sales Flexible Neuroendoscopes , by Region K Units (2021-2026)
  • Table 459. Neuroendoscopy Sales: by Application(K Units)
  • Table 460. Neuroendoscopy Sales Transnasal , by Region K Units (2021-2026)
  • Table 461. Neuroendoscopy Sales Intraventricular , by Region K Units (2021-2026)
  • Table 462. Neuroendoscopy Sales Transcranial , by Region K Units (2021-2026)
  • Table 463. Neuroendoscopy Sales: by Usability(K Units)
  • Table 464. Neuroendoscopy Sales Reusable , by Region K Units (2021-2026)
  • Table 465. Neuroendoscopy Sales Disposable , by Region K Units (2021-2026)
  • Table 466. Neuroendoscopy Sales: by End User(K Units)
  • Table 467. Neuroendoscopy Sales Hospitals , by Region K Units (2021-2026)
  • Table 468. Neuroendoscopy Sales Surgical Centers , by Region K Units (2021-2026)
  • Table 469. South America Neuroendoscopy Sales, by Country K Units (2021-2026)
  • Table 470. South America Neuroendoscopy Sales, by Type K Units (2021-2026)
  • Table 471. South America Neuroendoscopy Sales, by Application K Units (2021-2026)
  • Table 472. South America Neuroendoscopy Sales, by Usability K Units (2021-2026)
  • Table 473. South America Neuroendoscopy Sales, by End User K Units (2021-2026)
  • Table 474. South America Neuroendoscopy Sales, by Tumor Type K Units (2021-2026)
  • Table 475. Brazil Neuroendoscopy Sales, by Type K Units (2021-2026)
  • Table 476. Brazil Neuroendoscopy Sales, by Application K Units (2021-2026)
  • Table 477. Brazil Neuroendoscopy Sales, by Usability K Units (2021-2026)
  • Table 478. Brazil Neuroendoscopy Sales, by End User K Units (2021-2026)
  • Table 479. Brazil Neuroendoscopy Sales, by Tumor Type K Units (2021-2026)
  • Table 480. Argentina Neuroendoscopy Sales, by Type K Units (2021-2026)
  • Table 481. Argentina Neuroendoscopy Sales, by Application K Units (2021-2026)
  • Table 482. Argentina Neuroendoscopy Sales, by Usability K Units (2021-2026)
  • Table 483. Argentina Neuroendoscopy Sales, by End User K Units (2021-2026)
  • Table 484. Argentina Neuroendoscopy Sales, by Tumor Type K Units (2021-2026)
  • Table 485. Rest of South America Neuroendoscopy Sales, by Type K Units (2021-2026)
  • Table 486. Rest of South America Neuroendoscopy Sales, by Application K Units (2021-2026)
  • Table 487. Rest of South America Neuroendoscopy Sales, by Usability K Units (2021-2026)
  • Table 488. Rest of South America Neuroendoscopy Sales, by End User K Units (2021-2026)
  • Table 489. Rest of South America Neuroendoscopy Sales, by Tumor Type K Units (2021-2026)
  • Table 490. Asia Pacific Neuroendoscopy Sales, by Country K Units (2021-2026)
  • Table 491. Asia Pacific Neuroendoscopy Sales, by Type K Units (2021-2026)
  • Table 492. Asia Pacific Neuroendoscopy Sales, by Application K Units (2021-2026)
  • Table 493. Asia Pacific Neuroendoscopy Sales, by Usability K Units (2021-2026)
  • Table 494. Asia Pacific Neuroendoscopy Sales, by End User K Units (2021-2026)
  • Table 495. Asia Pacific Neuroendoscopy Sales, by Tumor Type K Units (2021-2026)
  • Table 496. China Neuroendoscopy Sales, by Type K Units (2021-2026)
  • Table 497. China Neuroendoscopy Sales, by Application K Units (2021-2026)
  • Table 498. China Neuroendoscopy Sales, by Usability K Units (2021-2026)
  • Table 499. China Neuroendoscopy Sales, by End User K Units (2021-2026)
  • Table 500. China Neuroendoscopy Sales, by Tumor Type K Units (2021-2026)
  • Table 501. Japan Neuroendoscopy Sales, by Type K Units (2021-2026)
  • Table 502. Japan Neuroendoscopy Sales, by Application K Units (2021-2026)
  • Table 503. Japan Neuroendoscopy Sales, by Usability K Units (2021-2026)
  • Table 504. Japan Neuroendoscopy Sales, by End User K Units (2021-2026)
  • Table 505. Japan Neuroendoscopy Sales, by Tumor Type K Units (2021-2026)
  • Table 506. India Neuroendoscopy Sales, by Type K Units (2021-2026)
  • Table 507. India Neuroendoscopy Sales, by Application K Units (2021-2026)
  • Table 508. India Neuroendoscopy Sales, by Usability K Units (2021-2026)
  • Table 509. India Neuroendoscopy Sales, by End User K Units (2021-2026)
  • Table 510. India Neuroendoscopy Sales, by Tumor Type K Units (2021-2026)
  • Table 511. South Korea Neuroendoscopy Sales, by Type K Units (2021-2026)
  • Table 512. South Korea Neuroendoscopy Sales, by Application K Units (2021-2026)
  • Table 513. South Korea Neuroendoscopy Sales, by Usability K Units (2021-2026)
  • Table 514. South Korea Neuroendoscopy Sales, by End User K Units (2021-2026)
  • Table 515. South Korea Neuroendoscopy Sales, by Tumor Type K Units (2021-2026)
  • Table 516. Taiwan Neuroendoscopy Sales, by Type K Units (2021-2026)
  • Table 517. Taiwan Neuroendoscopy Sales, by Application K Units (2021-2026)
  • Table 518. Taiwan Neuroendoscopy Sales, by Usability K Units (2021-2026)
  • Table 519. Taiwan Neuroendoscopy Sales, by End User K Units (2021-2026)
  • Table 520. Taiwan Neuroendoscopy Sales, by Tumor Type K Units (2021-2026)
  • Table 521. Australia Neuroendoscopy Sales, by Type K Units (2021-2026)
  • Table 522. Australia Neuroendoscopy Sales, by Application K Units (2021-2026)
  • Table 523. Australia Neuroendoscopy Sales, by Usability K Units (2021-2026)
  • Table 524. Australia Neuroendoscopy Sales, by End User K Units (2021-2026)
  • Table 525. Australia Neuroendoscopy Sales, by Tumor Type K Units (2021-2026)
  • Table 526. Rest of Asia-Pacific Neuroendoscopy Sales, by Type K Units (2021-2026)
  • Table 527. Rest of Asia-Pacific Neuroendoscopy Sales, by Application K Units (2021-2026)
  • Table 528. Rest of Asia-Pacific Neuroendoscopy Sales, by Usability K Units (2021-2026)
  • Table 529. Rest of Asia-Pacific Neuroendoscopy Sales, by End User K Units (2021-2026)
  • Table 530. Rest of Asia-Pacific Neuroendoscopy Sales, by Tumor Type K Units (2021-2026)
  • Table 531. Europe Neuroendoscopy Sales, by Country K Units (2021-2026)
  • Table 532. Europe Neuroendoscopy Sales, by Type K Units (2021-2026)
  • Table 533. Europe Neuroendoscopy Sales, by Application K Units (2021-2026)
  • Table 534. Europe Neuroendoscopy Sales, by Usability K Units (2021-2026)
  • Table 535. Europe Neuroendoscopy Sales, by End User K Units (2021-2026)
  • Table 536. Europe Neuroendoscopy Sales, by Tumor Type K Units (2021-2026)
  • Table 537. Germany Neuroendoscopy Sales, by Type K Units (2021-2026)
  • Table 538. Germany Neuroendoscopy Sales, by Application K Units (2021-2026)
  • Table 539. Germany Neuroendoscopy Sales, by Usability K Units (2021-2026)
  • Table 540. Germany Neuroendoscopy Sales, by End User K Units (2021-2026)
  • Table 541. Germany Neuroendoscopy Sales, by Tumor Type K Units (2021-2026)
  • Table 542. France Neuroendoscopy Sales, by Type K Units (2021-2026)
  • Table 543. France Neuroendoscopy Sales, by Application K Units (2021-2026)
  • Table 544. France Neuroendoscopy Sales, by Usability K Units (2021-2026)
  • Table 545. France Neuroendoscopy Sales, by End User K Units (2021-2026)
  • Table 546. France Neuroendoscopy Sales, by Tumor Type K Units (2021-2026)
  • Table 547. Italy Neuroendoscopy Sales, by Type K Units (2021-2026)
  • Table 548. Italy Neuroendoscopy Sales, by Application K Units (2021-2026)
  • Table 549. Italy Neuroendoscopy Sales, by Usability K Units (2021-2026)
  • Table 550. Italy Neuroendoscopy Sales, by End User K Units (2021-2026)
  • Table 551. Italy Neuroendoscopy Sales, by Tumor Type K Units (2021-2026)
  • Table 552. United Kingdom Neuroendoscopy Sales, by Type K Units (2021-2026)
  • Table 553. United Kingdom Neuroendoscopy Sales, by Application K Units (2021-2026)
  • Table 554. United Kingdom Neuroendoscopy Sales, by Usability K Units (2021-2026)
  • Table 555. United Kingdom Neuroendoscopy Sales, by End User K Units (2021-2026)
  • Table 556. United Kingdom Neuroendoscopy Sales, by Tumor Type K Units (2021-2026)
  • Table 557. Netherlands Neuroendoscopy Sales, by Type K Units (2021-2026)
  • Table 558. Netherlands Neuroendoscopy Sales, by Application K Units (2021-2026)
  • Table 559. Netherlands Neuroendoscopy Sales, by Usability K Units (2021-2026)
  • Table 560. Netherlands Neuroendoscopy Sales, by End User K Units (2021-2026)
  • Table 561. Netherlands Neuroendoscopy Sales, by Tumor Type K Units (2021-2026)
  • Table 562. Rest of Europe Neuroendoscopy Sales, by Type K Units (2021-2026)
  • Table 563. Rest of Europe Neuroendoscopy Sales, by Application K Units (2021-2026)
  • Table 564. Rest of Europe Neuroendoscopy Sales, by Usability K Units (2021-2026)
  • Table 565. Rest of Europe Neuroendoscopy Sales, by End User K Units (2021-2026)
  • Table 566. Rest of Europe Neuroendoscopy Sales, by Tumor Type K Units (2021-2026)
  • Table 567. MEA Neuroendoscopy Sales, by Country K Units (2021-2026)
  • Table 568. MEA Neuroendoscopy Sales, by Type K Units (2021-2026)
  • Table 569. MEA Neuroendoscopy Sales, by Application K Units (2021-2026)
  • Table 570. MEA Neuroendoscopy Sales, by Usability K Units (2021-2026)
  • Table 571. MEA Neuroendoscopy Sales, by End User K Units (2021-2026)
  • Table 572. MEA Neuroendoscopy Sales, by Tumor Type K Units (2021-2026)
  • Table 573. Middle East Neuroendoscopy Sales, by Type K Units (2021-2026)
  • Table 574. Middle East Neuroendoscopy Sales, by Application K Units (2021-2026)
  • Table 575. Middle East Neuroendoscopy Sales, by Usability K Units (2021-2026)
  • Table 576. Middle East Neuroendoscopy Sales, by End User K Units (2021-2026)
  • Table 577. Middle East Neuroendoscopy Sales, by Tumor Type K Units (2021-2026)
  • Table 578. Africa Neuroendoscopy Sales, by Type K Units (2021-2026)
  • Table 579. Africa Neuroendoscopy Sales, by Application K Units (2021-2026)
  • Table 580. Africa Neuroendoscopy Sales, by Usability K Units (2021-2026)
  • Table 581. Africa Neuroendoscopy Sales, by End User K Units (2021-2026)
  • Table 582. Africa Neuroendoscopy Sales, by Tumor Type K Units (2021-2026)
  • Table 583. North America Neuroendoscopy Sales, by Country K Units (2021-2026)
  • Table 584. North America Neuroendoscopy Sales, by Type K Units (2021-2026)
  • Table 585. North America Neuroendoscopy Sales, by Application K Units (2021-2026)
  • Table 586. North America Neuroendoscopy Sales, by Usability K Units (2021-2026)
  • Table 587. North America Neuroendoscopy Sales, by End User K Units (2021-2026)
  • Table 588. North America Neuroendoscopy Sales, by Tumor Type K Units (2021-2026)
  • Table 589. United States Neuroendoscopy Sales, by Type K Units (2021-2026)
  • Table 590. United States Neuroendoscopy Sales, by Application K Units (2021-2026)
  • Table 591. United States Neuroendoscopy Sales, by Usability K Units (2021-2026)
  • Table 592. United States Neuroendoscopy Sales, by End User K Units (2021-2026)
  • Table 593. United States Neuroendoscopy Sales, by Tumor Type K Units (2021-2026)
  • Table 594. Canada Neuroendoscopy Sales, by Type K Units (2021-2026)
  • Table 595. Canada Neuroendoscopy Sales, by Application K Units (2021-2026)
  • Table 596. Canada Neuroendoscopy Sales, by Usability K Units (2021-2026)
  • Table 597. Canada Neuroendoscopy Sales, by End User K Units (2021-2026)
  • Table 598. Canada Neuroendoscopy Sales, by Tumor Type K Units (2021-2026)
  • Table 599. Mexico Neuroendoscopy Sales, by Type K Units (2021-2026)
  • Table 600. Mexico Neuroendoscopy Sales, by Application K Units (2021-2026)
  • Table 601. Mexico Neuroendoscopy Sales, by Usability K Units (2021-2026)
  • Table 602. Mexico Neuroendoscopy Sales, by End User K Units (2021-2026)
  • Table 603. Mexico Neuroendoscopy Sales, by Tumor Type K Units (2021-2026)
  • Table 604. Neuroendoscopy: by Type(USD/Units)
  • Table 605. Research Programs/Design for This Report
  • Table 606. Key Data Information from Secondary Sources
  • Table 607. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Neuroendoscopy: by Type USD Million (2015-2020)
  • Figure 5. Global Neuroendoscopy: by Application USD Million (2015-2020)
  • Figure 6. Global Neuroendoscopy: by Usability USD Million (2015-2020)
  • Figure 7. Global Neuroendoscopy: by End User USD Million (2015-2020)
  • Figure 8. South America Neuroendoscopy Share (%), by Country
  • Figure 9. Asia Pacific Neuroendoscopy Share (%), by Country
  • Figure 10. Europe Neuroendoscopy Share (%), by Country
  • Figure 11. MEA Neuroendoscopy Share (%), by Country
  • Figure 12. North America Neuroendoscopy Share (%), by Country
  • Figure 13. Global Neuroendoscopy: by Type K Units (2015-2020)
  • Figure 14. Global Neuroendoscopy: by Application K Units (2015-2020)
  • Figure 15. Global Neuroendoscopy: by Usability K Units (2015-2020)
  • Figure 16. Global Neuroendoscopy: by End User K Units (2015-2020)
  • Figure 17. South America Neuroendoscopy Share (%), by Country
  • Figure 18. Asia Pacific Neuroendoscopy Share (%), by Country
  • Figure 19. Europe Neuroendoscopy Share (%), by Country
  • Figure 20. MEA Neuroendoscopy Share (%), by Country
  • Figure 21. North America Neuroendoscopy Share (%), by Country
  • Figure 22. Global Neuroendoscopy: by Type USD/Units (2015-2020)
  • Figure 23. Global Neuroendoscopy share by Players 2020 (%)
  • Figure 24. Global Neuroendoscopy share by Players (Top 3) 2020(%)
  • Figure 25. Global Neuroendoscopy share by Players (Top 5) 2020(%)
  • Figure 26. BCG Matrix for key Companies
  • Figure 27. KARL STORZ (Germany) Revenue, Net Income and Gross profit
  • Figure 28. KARL STORZ (Germany) Revenue: by Geography 2020
  • Figure 29. B. Braun (Germany) Revenue, Net Income and Gross profit
  • Figure 30. B. Braun (Germany) Revenue: by Geography 2020
  • Figure 31. Ackermann Instrumente (Germany) Revenue, Net Income and Gross profit
  • Figure 32. Ackermann Instrumente (Germany) Revenue: by Geography 2020
  • Figure 33. Adeor Medical (Germany) Revenue, Net Income and Gross profit
  • Figure 34. Adeor Medical (Germany) Revenue: by Geography 2020
  • Figure 35. Hangzhou Hawk Optical Electronic Instruments (China) Revenue, Net Income and Gross profit
  • Figure 36. Hangzhou Hawk Optical Electronic Instruments (China) Revenue: by Geography 2020
  • Figure 37. Machida Endoscope (Japan) Revenue, Net Income and Gross profit
  • Figure 38. Machida Endoscope (Japan) Revenue: by Geography 2020
  • Figure 39. Tonglu Wanhe Medical Instrument (China) Revenue, Net Income and Gross profit
  • Figure 40. Tonglu Wanhe Medical Instrument (China) Revenue: by Geography 2020
  • Figure 41. Schindler Endoskopie (Germany) Revenue, Net Income and Gross profit
  • Figure 42. Schindler Endoskopie (Germany) Revenue: by Geography 2020
  • Figure 43. Clarus Medical (United States) Revenue, Net Income and Gross profit
  • Figure 44. Clarus Medical (United States) Revenue: by Geography 2020
  • Figure 45. LocaMed (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 46. LocaMed (United Kingdom) Revenue: by Geography 2020
  • Figure 47. Global Neuroendoscopy: by Type USD Million (2021-2026)
  • Figure 48. Global Neuroendoscopy: by Application USD Million (2021-2026)
  • Figure 49. Global Neuroendoscopy: by Usability USD Million (2021-2026)
  • Figure 50. Global Neuroendoscopy: by End User USD Million (2021-2026)
  • Figure 51. South America Neuroendoscopy Share (%), by Country
  • Figure 52. Asia Pacific Neuroendoscopy Share (%), by Country
  • Figure 53. Europe Neuroendoscopy Share (%), by Country
  • Figure 54. MEA Neuroendoscopy Share (%), by Country
  • Figure 55. North America Neuroendoscopy Share (%), by Country
  • Figure 56. Global Neuroendoscopy: by Type K Units (2021-2026)
  • Figure 57. Global Neuroendoscopy: by Application K Units (2021-2026)
  • Figure 58. Global Neuroendoscopy: by Usability K Units (2021-2026)
  • Figure 59. Global Neuroendoscopy: by End User K Units (2021-2026)
  • Figure 60. South America Neuroendoscopy Share (%), by Country
  • Figure 61. Asia Pacific Neuroendoscopy Share (%), by Country
  • Figure 62. Europe Neuroendoscopy Share (%), by Country
  • Figure 63. MEA Neuroendoscopy Share (%), by Country
  • Figure 64. North America Neuroendoscopy Share (%), by Country
  • Figure 65. Global Neuroendoscopy: by Type USD/Units (2021-2026)
List of companies from research coverage that are profiled in the study
  • KARL STORZ (Germany)
  • B. Braun (Germany)
  • Ackermann Instrumente (Germany)
  • Adeor Medical (Germany)
  • Hangzhou Hawk Optical Electronic Instruments (China)
  • Machida Endoscope (Japan)
  • Tonglu Wanhe Medical Instrument (China)
  • Schindler Endoskopie (Germany)
  • Clarus Medical (United States)
  • LocaMed (United Kingdom)
Additional players considered in the study are as follows:
Visionsense Corporation (United States)
Select User Access Type

Key Highlights of Report


Mar 2021 227 Pages 94 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global (United States, European Union and China) Neuroendoscopy Quantitative research analysis
Global (United States, European Union and China) Neuroendoscopy Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Know More About Global (United States, European Union and China) Neuroendoscopy Report?

Have a Query? Click Here

Other Related Reports

Medical Automation Comprehensive Study by Type (Diagnostics & Monitoring, Medical Logistics & Training, Lab & Pharmacy Automation, Therapeutics), Medical Logistics & Training Automation (Logistics Au...
$ 3750
Medical Transport Services Comprehensive Study by Type (Medical Products, Incubator Transport, Mobile Treatment Facilities, Patient Transport), Application (Hospitals, Private Paying Customers, Nursi...
$ 3350
Compression Therapy Comprehensive Study by Type (Compression Stockings, Compression Bandages & Wraps, Compression Braces, Compression Pumps, Other), Application (Varicose Vein Treatment, Deep Vein Th...
$ 3750
Vascular Imaging Comprehensive Study by Application (Diagnostic, Therapeutic), Procedure (Coronary Angiography, Peripheral Angiography, Vascular Ultrasound, Cerebral Angiography, Microangiography, Ot...
$ 3750
Geriatric Care Services Comprehensive Study by Service Provider (Public, Private), Service (Home Care, Community Care, • Hospitals, • Institutional Centers, • Nursing Homes, • Others) Players and Reg...
$ 3500
Spinal Muscular Atrophy Comprehensive Study by Type (Type I, Type II, Type III, Type IV), Application (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Others), Treatment (Gene Therapy, Dr...
$ 3450